Members of the Justice Department Community Relations Program received late-night letters giving them the option to return, ...

After a brutal 26% decline in 2025, Block ( XYZ 0.79%) has begun to regain ground in early 2026. Even so, investors appear ...

This article was reviewed by Lynn Marie Morski, MD, JD. Key Takeaways: Intermittent fasting might benefit women over 50 by ...

As of 2025, 54% of all Medicare beneficiaries were enrolled in Medicare Advantage (MA). The average Medicare beneficiary had a choice of over ...

The victor who emerges from a crowded eight-candidate Democratic ticket will face off against the lone Republican running for ...

Brex reports that recurring revenue, a predictable income stream, is key for modern business growth and stability, ...

The proposed California billionaire tax promises $100B—but critics warn legal flaws, design risks, and billionaire exits ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

CHARLOTTE, N.C., Jan. 21, 2026 (GLOBE NEWSWIRE) -- isolved®, a provider of human capital management (HCM) solutions that help organizations ...

The mysterious Hyunmoo-5 short-range ballistic missile is estimated to carry a monstrous conventional warhead weighing over ...

ASTER fell over 12% to a new all-time low despite activating protocol-funded buybacks. The DEX is allocating 20-40% of daily fees to token repurchases.

Genmab shifts to innovation-led growth with 21% revenue, 52% operating profit, $3.4B cash, Epkinly, Rina-S, and Anthropic AI ...